News

Blood Proteins May Predict MASLD Up to 16 Years Before Symptoms - (https://news.ddw.org/news/blood-proteins-may-predict-masld ...
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
Liver disease is on the rise and it is very important to protect this vital organ as the world we live in is full of toxins.
A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...
Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...